Earnings Preview: Rogers to Report Financial Results Post-market on October 24
Roche Receives FDA Approval for the First Companion Diagnostic to Identify Patients With Gastric and Gastroesophageal Junction Cancer Eligible for Targeted Treatment With VYLOY
Express News | Roche Receives FDA Approval for the First Companion Diagnostic to Identify Patients With Gastric and Gastroesophageal Junction Cancer Eligible for Targeted Treatment With Vyloy
Baylin Technologies Announces Deployment of Multibeam Antennas for Upcoming High-Profile Events at Rogers Stadium, Toronto and BC Place, Vancouver
Manifest Meets Gen Z Where They Are With Launch of New Self-Empowerment Wellness App
Rogers Communication (RCI) Reports Next Week: Wall Street Expects Earnings Growth
Rogers Communications Price Target Lowered to $63 at Desjardins
Deloitte: Holiday Shoppers Expected to Increase Spending
Space Stocks Rise After SpaceX Captures Booster in Fifth Starship Flight Test
Rogers Corporation Schedules Third Quarter 2024 Earnings Call for October 24
Rogers Communications Price Target Lowered to C$71.50 From C$72 at Scotiabank
As Hurricane Milton Closes In, Del-Air Urges Homeowners to Take Safety Precautions During the Storm
Cove Capital Investments Fully Subscribes Its Rogers Business Park Opportunity 73 Delaware Statutory Trust Offering in Fulshear, TX
Barclays Remains a Buy on Rogers Communication (RCI)
Rogers Communications Strikes Deal for Discovery Content in Canada
Rogers Confirms Plans to Launch Warner Bros. Discovery Brands in 2025
Survey Commissioned by Roche Shows That HPV Infection, Which Causes 99% of All Cervical Cancer Cases, Remains Largely Misunderstood by the General Public
Canada Regulator Targets BCE, Rogers and Telus Over Roaming Fees -- Market Talk
The U.S. Port Strike Is Over. This Is What It Means for Transportation and Shipping Stocks
UBS Previews Rogers Q3